autologous osteoblasts
Cell therapyexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Oct 1, 2003 (NCT02890537)
Timeline
Indications
Mechanism of action
- BoneTissue restoration
Bone tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous osteoblastic cell
- autologous osteoblastic cells
- preob
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02061995 | Phase 2 | Dec 1, 2013 | Erasmus University Rotterdam |
| NCT01756326 | Phase 2/Phase 3 (Phase 3) | Jun 1, 2012 | Bone Therapeutics S.A |
| NCT01529008 | Phase 3 | Nov 1, 2011 | Bone Therapeutics S.A |
| NCT02890537 | Phase 2 | Oct 1, 2003 | Bone Therapeutics S.A, Erasmus University Rotterdam, University of Liege |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bone Therapeutics S.A | For profit | 3 | 2 | 2 | 2003 |
| Erasmus University Rotterdam | Academic/Hospital | 2 | 2 | 1 | 2003 |
| University of Liege | Academic/Hospital | 1 | 0 | 1 | 2003 |
3 organizations
Page 1 / 1